Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1644143

registered interest
date	13/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to paragraphs 2.7 and 2.8: Service Performance, of the National Homecare Medicines Committee Good Practice Principles: Provision of Manufacturer Funded Homecare Medicines Services, published in February 2018, what information his Department holds on any notifications between (a) manufacturers and that Committee or individual Clinical Referring Centres and (b) the NHMC or individual Clinical Referring Centres and manufacturers on trends in the performance of a Homecare Provider which can be reasonably considered to compromise patient safety; and whether he has made an assessment of the adequacy of measures to protect patient safety.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	189330
answer	answer is ministerial correction date of answer 26/06/2023 answer text <p>Providers of Homecare Medicines services operate in a highly regulated environment with obligations to record and monitor quality metrics, including any trends. To monitor industry trends, providers provide the same data set to the trade association, the National Clinical Homecare Association (NCHA), allowing for the aggregation of all providers metrics. The NCHA report that delivery performance of providers (delivery to patients on the agreed date) was 99.0% in 2020; 98.6% in 2021; and 98.8% in 2022. Formal complaints and incidents are also monitored and the data shows that the percentage of complaints raised was 1.4% in 2020; 1.6% in 2021 and 1.8% in 2022 of active patients (this refers to complaints opened, not upheld).</p><p>The National Homecare Medicines Committee (NHMC) is not aware of having received any formal written notifications from manufacturers where declining trends can be reasonably considered to compromise patient safety. Information from clinical referring centres is routed via regional National Health Service homecare specialists, as NHMC members.</p><p>When the Key Performance Indicators indicate that the service levels of a provider on a national or regional framework or contract are not to the standard expected, the NHMC addresses the issue by meeting with individual providers to discuss safety and performance issues. If necessary, the regulators the Care Quality Commission and the General Pharmaceutical Council are also informed.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 187793 question first answered 26/06/2023 15:56:01 answering member 4423 label Biography information for Will Quince previous answer version 82330 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4645 label Biography information for Emma Hardy

1641883

registered interest
date	05/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the impact of trends in the level of homecare medicines services on patient safety.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	187793
answer	answer is ministerial correction date of answer 26/06/2023 answer text <p>Providers of Homecare Medicines services operate in a highly regulated environment with obligations to record and monitor quality metrics, including any trends. To monitor industry trends, providers provide the same data set to the trade association, the National Clinical Homecare Association (NCHA), allowing for the aggregation of all providers metrics. The NCHA report that delivery performance of providers (delivery to patients on the agreed date) was 99.0% in 2020; 98.6% in 2021; and 98.8% in 2022. Formal complaints and incidents are also monitored and the data shows that the percentage of complaints raised was 1.4% in 2020; 1.6% in 2021 and 1.8% in 2022 of active patients (this refers to complaints opened, not upheld).</p><p>The National Homecare Medicines Committee (NHMC) is not aware of having received any formal written notifications from manufacturers where declining trends can be reasonably considered to compromise patient safety. Information from clinical referring centres is routed via regional National Health Service homecare specialists, as NHMC members.</p><p>When the Key Performance Indicators indicate that the service levels of a provider on a national or regional framework or contract are not to the standard expected, the NHMC addresses the issue by meeting with individual providers to discuss safety and performance issues. If necessary, the regulators the Care Quality Commission and the General Pharmaceutical Council are also informed.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 189330 question first answered 26/06/2023 15:56:01 answering member 4423 label Biography information for Will Quince previous answer version 79837 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4645 label Biography information for Emma Hardy

1551699

registered interest
date	14/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the quality assurance and governance processes set out in contracts for homecare medicines service in England include as key performance indicators for monthly performance assessment the number of (a) delayed deliveries, (b) delayed treatment initiations and (c) missed doses.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	110814
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>Homecare providers are assessed on a monthly basis against national Key Performance Indicators (KPIs) for National Health Service framework agreements and regionally for local contracting. Regular formal assessments are made through face-to-face meetings with the National Homecare Medicines Committee (NHMC) and NHS England. These KPIs include delayed deliveries and missed doses.</p><p>When KPIs or NHS hospitals report that service levels do not meet the relevant standards, the NHMC enacts an escalation process. Where this process is in place, the affected homecare provider will provide each NHS organisation with a summary of the issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed.</p><p>The National Clinical Homecare Association is working with the British Society for Rheumatology to arrange discussions with its members, the NHMC and NHS England regarding the safety and performance of the Homecare Medicine Delivery Service.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 110815 question first answered 20/12/2022 11:40:12 answering member 4423 label Biography information for Will Quince previous answer version 43396 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4645 label Biography information for Emma Hardy

1551700

registered interest
date	14/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what powers NHS England has to hold homecare medicines services providers to account for (a) delayed deliveries, (b) delayed treatment initiation and (c) missed doses of medicines.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	110815
answer	answer is ministerial correction date of answer 20/12/2022 answer text <p>Homecare providers are assessed on a monthly basis against national Key Performance Indicators (KPIs) for National Health Service framework agreements and regionally for local contracting. Regular formal assessments are made through face-to-face meetings with the National Homecare Medicines Committee (NHMC) and NHS England. These KPIs include delayed deliveries and missed doses.</p><p>When KPIs or NHS hospitals report that service levels do not meet the relevant standards, the NHMC enacts an escalation process. Where this process is in place, the affected homecare provider will provide each NHS organisation with a summary of the issues, mitigations and expected timescales for recovery. If necessary, the Care Quality Commission and the General Pharmaceutical Council are also informed.</p><p>The National Clinical Homecare Association is working with the British Society for Rheumatology to arrange discussions with its members, the NHMC and NHS England regarding the safety and performance of the Homecare Medicine Delivery Service.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 110814 question first answered 20/12/2022 11:40:12 answering member 4423 label Biography information for Will Quince previous answer version 43419 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4645 label Biography information for Emma Hardy

1550571

registered interest
date	12/12/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department last assessed the essential medicines buffer stock to ensure it has the (a) appropriate products and (b) adequate volume of those products.
tabling member constituency	Ilford North
tabling member printed	Wes Streeting
uin	108288
answer	answer is ministerial correction date of answer 22/12/2022 answer text <p>The Essential Medicines Buffer Stock (EMBS) programme formally ended in 2019/2020. A small number of products were, however, retained in the EMBS to March 2022 as part of the COVID-19 Supportive Medicines stockpile. There are no plans to reinstate the EMBS.</p><p>We are taking decisive action to address temporary supply issues with some antibiotics that can be used to treat Strep A and to improve access to these medicines by continuing to work with manufacturers and wholesalers to speed up deliveries, bring forward stock they have to help ensure it gets to where it is needed and to boost supply to meet demand as quickly as possible.</p><p>Further, Serious Shortage Protocols have been issued across the United Kingdom for penicillin medicines, which will help mitigate local supply issues and allow pharmacists to supply alternative forms of the medicine, or alternative antibiotics, if they don’t have the specific product stated on the prescription.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 108287 question first answered 22/12/2022 11:44:16 answering member 4423 label Biography information for Will Quince previous answer version 43405 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4504 label Biography information for Wes Streeting